Transformación anaplásica del carcinoma tiroideo de células de Hürthle

  1. D. Sánchez Relinque 1
  2. E. Sánchez Legaza 2
  3. R. Guerrero Cauqui 3
  4. T. Gómez Sánchez 1
  5. R. García Ligero 3
  6. E. García Romero 1
  1. 1 Servicio de Cirugía General y Aparato Digestivo. Hospital Punta de Europa de Algeciras, Cádiz
  2. 2 Servicio de ORL. Hospital Punta de Europa de Algeciras, Cádiz
  3. 3 Servicio de Anatomía Patológica. Hospital Punta de Europa de Algeciras, Cádiz
Mostrar afiliaciones +
Revista:
Cirugía Andaluza

ISSN: 2695-3811,  1130-3212

Año de publicación: 2009

Volumen: 20

Número: 3

Páginas: 300-304

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: Cirugía Andaluza

Resumen

El carcinoma anaplásico de tiroides es una de las neoplasias primarias malignas más infrecuentes. Aunque son muchas las incógnitas todavía existentes respecto a su naturaleza, su evolución es invariablemente fatal y acompaña una supervivencia media de 4-7 meses desde el momento del diagnóstico. La clínica más común es una tumoración tiroidea leñosa de rápido crecimiento; en los diagnósticos diferenciales habituales se deben incluir el bocio multinodular o un cáncer tiroideo previo de larga duración, pues realizando un diagnóstico precoz se puede aumentar la supervivencia del paciente.

Referencias bibliográficas

  • Sherman SI. Thyroid carcinoma. Lancet 2003; 361: 501-11.
  • Wiseman SM, Loree TR, Rigual NR, Hicks WL, Douglas WG, Anderson GR, Stoler DL. Anaplastic transformation of thyroid cancer: review of clinical, pathologic and molecular evidence provides new insights into disease biology and future therapy. Head Neck 2003; 662-70.
  • Ain KB. Anaplastic Thyroid Carcinoma: behavior, biology and therapeutic approaches. Thyroid 1998; 8(8):715-26.
  • Clark OH. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is assodiation is associated with prolonged survival. Cancer 2001; 91 (12): 2335-42.
  • Sugino K, Ito K, Minura T, Nagahama M, Fukunari N, Kubo A, Iwasaki H. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 2002; 131: 245- 8.
  • Problems in Pathology. Edited by Beninnington J Philadelphia: WB Saunders; 1990: 253-74.
  • Cornett WR, Sharma AK, Day TA, Richardson MS, Hoda RS, van Heerden JA, Fernandes JK. Anaplastic thyroid carcinoma: an overview. Curr Oncol Rep 2007; 9 (2): 152-8.
  • Nakamura T, Yana I, Kobayashi T, Shin E, Karakawa K, Fujita S, Miya A, Mori T, Nishisho I, Takai S. P53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 1992; 83: 1293-8.
  • Lazzereschi D, Ranieri A, Mincione G, Taccogna S, Nardi F, Colletta G. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein. Cancer Res 1997; 57: 2071-6.
  • Garcia- Rostan G, Tallini G, Herrero A, D’Aquila TG, Carcangiu ML, Rimm DL. Frequent mutation and nuclear localization fo beta-catenin in anaplastic thyroid carcinoma. Cancer Res 1999; 59: 1811-5.
  • Venkatesh YS, Ordoñez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases. Cancer 1990; 66 (2): 321- 30.
  • Samaan NA, Ordoñez NG. Uncommon types of thyroid cancer. Endocrinol Metab Clinn North Am 1990; 19: 637-48.
  • Nishiyama RH, Dunn EL, Thompson NW. Anaplastic spindlecell and giant -cell tumors of the thyroid gland. Cancer 1972; 30 (1): 113-27.
  • Shvero J, Gal R, R Avidor, Hadar T, Kessler E. Anaplastic thyroid carcinoma: A clinical, histologic and immunohistochemical study. Cancer 1988; 62 (2): 319-325.
  • Rossi R, Cady B, Meissner WA, Sedgwick CE, Werber J. Prognosis of undifferentiated carcinoma and lymphoma of the thyroid. Am J Surg 1978; 135: 589-96.
  • Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors and treatment approaches. Ann Surg Oncol 2006;13(4): 453-64.
  • Haigh PI. Anaplastic thyroid carcinoma. Curr SugTreat Options Oncol 2000; 1 (4): 353-7.
  • Sugino K, Ito K, Minura T, Nagahama M, Fukunari N, Kubo A, Iwasaki H. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery 2002; 131; 245-8.
  • Sugitani I, Kasai N, Fugimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategies for anaplastic carcinoma of the thyroid. World J Surg 2001; 25: 617-22.
  • Kiara M, Miyauchi A, Yamauchi A, Yokomise H. Prognostic factors of anaplastic thyroid carcinoma. Surg Today 2004; 34: 394-8.
  • Nel CJ, Van Heerden JA, Goellner JR, Gharib H, McConahey WM, Taylor WF, Grant CS. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc 1985; 60: 51-8.
  • Kurukahvecioglu O, Bahadir E, Poyraz A, Tezel E, Taneri F. Anaplastic Thyroid Carcinoma with long term survival after combined treatment: case report. Endocrine Regulations 2007; 41: 41-4.
  • Guiffrida D, Gharib H. Anaplastic thyroid carcinoma: Current diagnosis and treatment. Annals of Oncology 2000; 11: 1083-9.
  • Chandrakanth A, Shaha A. Anaplastic Thyroid Carcinoma: biology, pathogenesis, prognostic and treatment approaches. Annals Surgical Oncology 2006; 13 (4): 453-64.
Fuente de los datos: Dialnet